# EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers

> **NCT07590622** · NA · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 88 (estimated)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** LH BLU
- **DIETARY_SUPPLEMENT:** ONS

## Key facts

- **NCT ID:** NCT07590622
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2031-06
- **Final completion:** 2031-06
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07590622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07590622, "EAT-ING: Enhancing Anticancer Treatment Safety Via Immunomodulatory Nutritional Support in Advanced Gastrointestinal Cancers". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07590622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*